We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hair Analysis May Help Diagnose Cushing Syndrome

By LabMedica International staff writers
Posted on 23 Feb 2017
Print article
Image: Research shows analyzing cortisol levels in hair close to the scalp may be a reliable diagnostic method for Cushing\'s syndrome (Photo courtesy of Professor Antonella Tosti, MD).
Image: Research shows analyzing cortisol levels in hair close to the scalp may be a reliable diagnostic method for Cushing\'s syndrome (Photo courtesy of Professor Antonella Tosti, MD).
Cushing's syndrome is a condition that occurs as a result of exposure to high levels of cortisol for an extended period. The diagnosis of Cushing syndrome is often difficult and time-consuming, requiring 24 hours to analyze blood and urine tests, brain imaging tests, and tissue samples from sinuses at the base of the skull.

Excessive cortisol levels can also be caused when a tumor develops inside one of the body's glands, such as the pituitary or adrenal glands, although this is less common. The adrenal glands produce cortisol. Elevated cortisol levels can be triggered as a side effect of corticosteroid medications that are used to treat inflammatory diseases, such as lupus, asthma, and rheumatoid arthritis.

Scientists associated with the US National Institute of Child Health and Human Development enrolled 30 patients (26.5 ± 18.9 years, 75% female, and 75% Caucasian) with Cushing Syndrome and six patients who did not have the condition. The number of patients in the study was small, compared to studies of patients with more common disorders, because Cushing Syndrome is rare and it is difficult to recruit a large number of patients. The study participants provided hair samples divided into three equal segments.

The team analyzed diurnal serum cortisol, 24 hour urinary free cortisol corrected for body surface area (UFC/BSA), and 24 hour urinary 17-hydroxysteroids corrected for creatinine (17OHS/Cr). The investigators took 3-cm hair samples nearest to the scalp, cut into 1-cm segments (proximal, medial, and distal), which were analyzed for cortisol by enzyme immunoassay and measured as pmol cortisol/g dry hair. Hair cortisol levels were compared with laboratory testing done within previous two months of the evaluation.

The scientists reported that proximal hair cortisol was higher in Cushing syndrome patients (266.6 ± 738.4 pmol/g) than control patients (38.9 ± 25.3 pmol/g). Proximal hair cortisol was highest of all segments in 25/36 (69%) patients. Among all subjects, proximal hair cortisol was strongly correlated with UFC/BSA midnight serum cortisol and 17OHS/Cr, which trended towards significance. Hair cortisol levels closely correlated with cortisol levels in urine, blood.

The authors concluded that among the three examined hair segments; proximal hair contained the highest cortisol levels and correlated the most with the initial biochemical tests for Cushing syndrome in their study. Further studies are needed to validate proximal hair cortisol in the diagnostic workup for Cushing syndrome. Mihail Zilbermint, MD, an endocrinologist and senior author of the study said, “Our results are encouraging. We are hopeful that hair analysis may ultimately prove useful as a less invasive screening test for Cushing's syndrome or in helping to confirm the diagnosis.” The study was published on February 13, 2017, in the journal Endocrine.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.